Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2023
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Food and Drug Amendments of 2022
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2022 · fourth_quarter · Q4
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Food and Drug Amendments of 2022
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Food and Drug Amendments of 2022
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Humane Cosmetics Act of 2021
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Humane Cosmetics Act of 2021
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Humane Cosmetics Act of 2021
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Cosmetic Safety Enhancement Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Cosmetic Safety Enhancement Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Cosmetic Safety Enhancement Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Cosmetic Safety Enhancement Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Humane Cosmetics Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Cosmetic Safety Enhancement Act of 2019
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
FDA Cosmetic Safety and Modernization Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
FDA Cosmetic Safety and Modernization Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
FDA Cosmetic Safety and Modernization Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
FDA Cosmetic Safety and Modernization Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act
Personal Care Products Safety Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
FDA Cosmetic Safety and Modernization Act
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: COVINGTON & BURLING LLP
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
2022 · third_quarter · Q3
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Education and outreach related to plant-based meat products.
Filing targets: SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Federal cosmetic legislation.
Filing targets: SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act; S. 3357, Humane Cosmetics Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667, Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
Federal cosmetic legislation.
Filing targets: SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Filing targets: SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Education and outreach related to plant-based meat products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Federal cosmetic legislation.
Filing targets: SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs; S.2100, Personal Care Products Safety Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Education and outreach related to plant-based meat products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Education and outreach related to plant-based meat products (*Brendan Parets did not lobby the U.S. Senate*)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Education and outreach related to plant-based meat products (*Brendan Parets did not lobby the U.S. Senate*)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Education and outreach related to plant-based meat products (*Brendan Parets did not lobby the U.S. Senate*)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279). The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Education and outreach related to plant-based meat products
Filing targets: HOUSE OF REPRESENTATIVES
BEYOND MEAT, INC. via COVINGTON & BURLING LLP
2019 · fourth_quarter · RR
Education and outreach related to plant-based meat products
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
CHANEL, INC. via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Federal cosmetic legislation
Filing targets: HOUSE OF REPRESENTATIVES
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHANEL, INC. via COVINGTON & BURLING LLP
2019 · second_quarter · RR
Federal cosmetic legislation
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products. The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2019 · first_quarter · 1T
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Filing targets: SENATE
KIND LLC via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Federal activity regarding food labeling claims
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Filing targets: SENATE
KIND LLC via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Federal activity regarding food labeling claims
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIND LLC via COVINGTON & BURLING LLP
2018 · third_quarter · RR
Federal activity regarding food labeling claims
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Filing targets: SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Filing targets: SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Filing targets: SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act
Filing targets: SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PERSONAL CARE PRODUCTS COUNCIL via COVINGTON & BURLING LLP
2017 · second_quarter · RR
Activities related to potential cosmetics legislative reform.
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Nutrition Facts Panel Rule implementation and impact
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MGP INGREDIENTS, INC. via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Nutrition Facts Panel Rule implementation and impact; Fugitive emissions from Whiskey barrels/aging warehouses.
Nutrition Facts Panel Rule implementation and impact; Fugitive emissions from Whiskey barrels/aging warehouses.